| Product Code: ETC13228573 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
Middle East Radiopharmaceuticals & Contrast Media Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Middle East Radiopharmaceuticals & Contrast Media Market Overview |
3.1 Middle East Regional Macro Economic Indicators |
3.2 Middle East Radiopharmaceuticals & Contrast Media Market Revenues & Volume, 2021 & 2031F |
3.3 Middle East Radiopharmaceuticals & Contrast Media Market - Industry Life Cycle |
3.4 Middle East Radiopharmaceuticals & Contrast Media Market - Porter's Five Forces |
3.5 Middle East Radiopharmaceuticals & Contrast Media Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 Middle East Radiopharmaceuticals & Contrast Media Market Revenues & Volume Share, By Type of Imaging Modality, 2021 & 2031F |
3.7 Middle East Radiopharmaceuticals & Contrast Media Market Revenues & Volume Share, By PET, 2021 & 2031F |
3.8 Middle East Radiopharmaceuticals & Contrast Media Market Revenues & Volume Share, By Diagnostic SPECT Application, 2021 & 2031F |
3.9 Middle East Radiopharmaceuticals & Contrast Media Market Revenues & Volume Share, By PET Applications, 2021 & 2031F |
3.10 Middle East Radiopharmaceuticals & Contrast Media Market Revenues & Volume Share, By Therapeutic Application, 2021 & 2031F |
3.11 Middle East Radiopharmaceuticals & Contrast Media Market Revenues & Volume Share, By Contrast Media Type, 2021 & 2031F |
3.12 Middle East Radiopharmaceuticals & Contrast Media Market Revenues & Volume Share, By Procedure, 2021 & 2031F |
3.12 Middle East Radiopharmaceuticals & Contrast Media Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Middle East Radiopharmaceuticals & Contrast Media Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Middle East Radiopharmaceuticals & Contrast Media Market Trends |
6 Middle East Radiopharmaceuticals & Contrast Media Market, 2021 - 2031 |
6.1 Middle East Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Type of Imaging Modality, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Middle East Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Tc-99, 2021 - 2031 |
6.1.3 Middle East Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Tl-201, 2021 - 2031 |
6.1.4 Middle East Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Ga-67, 2021 - 2031 |
6.1.5 Middle East Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By I-123, 2021 - 2031 |
6.1.6 Middle East Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Other SPECTs, 2021 - 2031 |
6.2 Middle East Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By PET, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Middle East Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By F-18, 2021 - 2031 |
6.2.3 Middle East Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Rb-82, 2021 - 2031 |
6.2.4 Middle East Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Other PETs, 2021 - 2031 |
6.3 Middle East Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Diagnostic SPECT Application, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Middle East Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Cardiology, 2021 - 2031 |
6.3.3 Middle East Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Neurology, 2021 - 2031 |
6.3.4 Middle East Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Thyroid, 2021 - 2031 |
6.3.5 Middle East Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Other SPECT Applications, 2021 - 2031 |
6.4 Middle East Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By PET Applications, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Middle East Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Oncology, 2021 - 2031 |
6.4.3 Middle East Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Cardology, 2021 - 2031 |
6.4.4 Middle East Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Neurology, 2021 - 2031 |
6.4.5 Middle East Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Other PET Applications, 2021 - 2031 |
6.5 Middle East Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Therapeutic Application, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 Middle East Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Thyroid, 2021 - 2031 |
6.5.3 Middle East Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Lymphoma, 2021 - 2031 |
6.5.4 Middle East Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Endocrine Tumors, 2021 - 2031 |
6.5.5 Middle East Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Other Therapeutic Applications, 2021 - 2031 |
6.6 Middle East Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Contrast Media Type, 2021 - 2031 |
6.6.1 Overview & Analysis |
6.6.2 Middle East Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Iodinated Contrast Media, 2021 - 2031 |
6.6.3 Middle East Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Gadolinium-based Contrast Media, 2021 - 2031 |
6.6.4 Middle East Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Microbubble Contrast Media, 2021 - 2031 |
6.6.5 Middle East Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Barium-based Contrast Media, 2021 - 2031 |
6.7 Middle East Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Procedure, 2021 - 2031 |
6.7.1 Overview & Analysis |
6.7.2 Middle East Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By X-ray/Computed Tomography (CT), 2021 - 2031 |
6.7.3 Middle East Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Magnetic Resnance Imaging (MRI), 2021 - 2031 |
6.7.4 Middle East Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Ultrasound, 2021 - 2031 |
6.8 Middle East Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Application, 2021 - 2031 |
6.8.1 Overview & Analysis |
6.8.2 Middle East Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Cardiovascular Disease, 2021 - 2031 |
6.8.3 Middle East Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Oncology, 2021 - 2031 |
6.8.4 Middle East Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Gastrointestinal Disorders, 2021 - 2031 |
6.8.5 Middle East Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Neurological Disorders, 2021 - 2031 |
6.8.6 Middle East Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Other Indications, 2021 - 2031 |
7 Middle East Radiopharmaceuticals & Contrast Media Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 Middle East Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Type of Imaging Modality, 2021 - 2031 |
7.2.1 Saudi Arabia Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Type of Imaging Modality, 2021 - 2031 |
7.2.2 UAE Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Type of Imaging Modality, 2021 - 2031 |
7.2.3 Kuwait Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Type of Imaging Modality, 2021 - 2031 |
7.2.4 Qatar Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Type of Imaging Modality, 2021 - 2031 |
7.2.5 Bahrain Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Type of Imaging Modality, 2021 - 2031 |
7.2.6 Oman Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Type of Imaging Modality, 2021 - 2031 |
7.2.7 Turkey Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Type of Imaging Modality, 2021 - 2031 |
7.2.8 Rest of Middle East Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Type of Imaging Modality, 2021 - 2031 |
7.3 Middle East Radiopharmaceuticals & Contrast Media Market Revenues & Volume Share, By PET, 2021 & 2031F |
7.3.1 Saudi Arabia Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By PET, 2021 - 2031 |
7.3.2 UAE Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By PET, 2021 - 2031 |
7.3.3 Kuwait Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By PET, 2021 - 2031 |
7.3.4 Qatar Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By PET, 2021 - 2031 |
7.3.5 Bahrain Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By PET, 2021 - 2031 |
7.3.6 Oman Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By PET, 2021 - 2031 |
7.3.7 Turkey Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By PET, 2021 - 2031 |
7.3.8 Rest of Middle East Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By PET, 2021 - 2031 |
7.4 Middle East Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Diagnostic SPECT Application, 2021 - 2031 |
7.4.1 Saudi Arabia Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Diagnostic SPECT Application, 2021 - 2031 |
7.4.2 UAE Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Diagnostic SPECT Application, 2021 - 2031 |
7.4.3 Kuwait Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Diagnostic SPECT Application, 2021 - 2031 |
7.4.4 Qatar Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Diagnostic SPECT Application, 2021 - 2031 |
7.4.5 Bahrain Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Diagnostic SPECT Application, 2021 - 2031 |
7.4.6 Oman Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Diagnostic SPECT Application, 2021 - 2031 |
7.4.7 Turkey Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Diagnostic SPECT Application, 2021 - 2031 |
7.4.8 Rest of Middle East Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Diagnostic SPECT Application, 2021 - 2031 |
7.5 Middle East Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By PET Applications, 2021 - 2031 |
7.5.1 Saudi Arabia Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By PET Applications, 2021 - 2031 |
7.5.2 UAE Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By PET Applications, 2021 - 2031 |
7.5.3 Kuwait Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By PET Applications, 2021 - 2031 |
7.5.4 Qatar Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By PET Applications, 2021 - 2031 |
7.5.5 Bahrain Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By PET Applications, 2021 - 2031 |
7.5.6 Oman Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By PET Applications, 2021 - 2031 |
7.5.7 Turkey Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By PET Applications, 2021 - 2031 |
7.5.8 Rest of Middle East Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By PET Applications, 2021 - 2031 |
7.6 Middle East Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Therapeutic Application, 2021 - 2031 |
7.6.1 Saudi Arabia Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Therapeutic Application, 2021 - 2031 |
7.6.2 UAE Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Therapeutic Application, 2021 - 2031 |
7.6.3 Kuwait Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Therapeutic Application, 2021 - 2031 |
7.6.4 Qatar Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Therapeutic Application, 2021 - 2031 |
7.6.5 Bahrain Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Therapeutic Application, 2021 - 2031 |
7.6.6 Oman Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Therapeutic Application, 2021 - 2031 |
7.6.7 Turkey Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Therapeutic Application, 2021 - 2031 |
7.6.8 Rest of Middle East Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Therapeutic Application, 2021 - 2031 |
7.7 Middle East Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Contrast Media Type, 2021 - 2031 |
7.7.1 Saudi Arabia Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Contrast Media Type, 2021 - 2031 |
7.7.2 UAE Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Contrast Media Type, 2021 - 2031 |
7.7.3 Kuwait Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Contrast Media Type, 2021 - 2031 |
7.7.4 Qatar Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Contrast Media Type, 2021 - 2031 |
7.7.5 Bahrain Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Contrast Media Type, 2021 - 2031 |
7.7.6 Oman Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Contrast Media Type, 2021 - 2031 |
7.7.7 Turkey Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Contrast Media Type, 2021 - 2031 |
7.7.8 Rest of Middle East Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Contrast Media Type, 2021 - 2031 |
7.8 Middle East Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Procedure, 2021 - 2031 |
7.8.1 Saudi Arabia Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Procedure, 2021 - 2031 |
7.8.2 UAE Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Procedure, 2021 - 2031 |
7.8.3 Kuwait Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Procedure, 2021 - 2031 |
7.8.4 Qatar Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Procedure, 2021 - 2031 |
7.8.5 Bahrain Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Procedure, 2021 - 2031 |
7.8.6 Oman Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Procedure, 2021 - 2031 |
7.8.7 Turkey Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Procedure, 2021 - 2031 |
7.8.8 Rest of Middle East Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Procedure, 2021 - 2031 |
7.9 Middle East Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Application, 2021 - 2031 |
7.9.1 Saudi Arabia Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Application, 2021 - 2031 |
7.9.2 UAE Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Application, 2021 - 2031 |
7.9.3 Kuwait Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Application, 2021 - 2031 |
7.9.4 Qatar Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Application, 2021 - 2031 |
7.9.5 Bahrain Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Application, 2021 - 2031 |
7.9.6 Oman Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Application, 2021 - 2031 |
7.9.7 Turkey Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Application, 2021 - 2031 |
7.9.8 Rest of Middle East Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Application, 2021 - 2031 |
8 Middle East Radiopharmaceuticals & Contrast Media Market Key Performance Indicators |
9 Middle East Radiopharmaceuticals & Contrast Media Market - Export/Import By Countries Assessment |
10 Middle East Radiopharmaceuticals & Contrast Media Market - Opportunity Assessment |
10.1 Middle East Radiopharmaceuticals & Contrast Media Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 Middle East Radiopharmaceuticals & Contrast Media Market Opportunity Assessment, By Type of Imaging Modality, 2021 & 2031F |
10.3 Middle East Radiopharmaceuticals & Contrast Media Market Opportunity Assessment, By PET, 2021 & 2031F |
10.4 Middle East Radiopharmaceuticals & Contrast Media Market Opportunity Assessment, By Diagnostic SPECT Application, 2021 & 2031F |
10.5 Middle East Radiopharmaceuticals & Contrast Media Market Opportunity Assessment, By PET Applications, 2021 & 2031F |
10.6 Middle East Radiopharmaceuticals & Contrast Media Market Opportunity Assessment, By Therapeutic Application, 2021 & 2031F |
10.7 Middle East Radiopharmaceuticals & Contrast Media Market Opportunity Assessment, By Contrast Media Type, 2021 & 2031F |
10.8 Middle East Radiopharmaceuticals & Contrast Media Market Opportunity Assessment, By Procedure, 2021 & 2031F |
10.9 Middle East Radiopharmaceuticals & Contrast Media Market Opportunity Assessment, By Application, 2021 & 2031F |
11 Middle East Radiopharmaceuticals & Contrast Media Market - Competitive Landscape |
11.1 Middle East Radiopharmaceuticals & Contrast Media Market Revenue Share, By Companies, 2022 |
11.2 Middle East Radiopharmaceuticals & Contrast Media Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here